Tipping the gatekeeper: S1P regulation of endothelial barrier function

Trends in Immunology

Volumn 28, Issue 3, 2007, Pages 102-107

  Rosen, Hugh ^a   Sanna, M Germana ^a   Cahalan, Stuart M ^a   Gonzalez Cabrera, Pedro J ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARYLPROPIONIC ACID DERIVATIVE; AUY 954; FINGOLIMOD; G PROTEIN COUPLED RECEPTOR; JTE 013; KRP 203; LIGAND; LYSOPHOSPHOLIPID; RECEPTOR BLOCKING AGENT; SEW 2871; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE 1 PHOSPHATE RECEPTOR; UNCLASSIFIED DRUG; VPC 23019; W 123; W 146;

ADAPTIVE IMMUNITY; AGONIST; ARTICLE; ENDOTHELIUM CELL; EVOKED RESPONSE; EXTRACELLULAR SPACE; HOMEOSTASIS; INFLAMMATION; INNATE IMMUNITY; LYMPH VESSEL ENDOTHELIUM; LYMPHOCYTE; NONHUMAN; PATHOPHYSIOLOGY; PLEIOTROPY; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CELL MOVEMENT; ENDOTHELIUM, VASCULAR; HUMANS; LYMPHOCYTES; LYSOPHOSPHOLIPIDS; PROPYLENE GLYCOLS; RECEPTORS, LYSOSPHINGOLIPID; SIGNAL TRANSDUCTION; SPHINGOSINE;

EID: 33847131347     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.it.2007.01.007     Document Type: Article

References (54)

1. Spiegel S., and Milstien M. Sphingosine 1-phosphate: an enigmatic signalling lipid. Nat. Rev. Mol. Cell Biol. 4 (2003) 397-407
2. Mandala S., et al. Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists. Science 296 (2002) 346-349
3. Kolesnick R. The therapeutic potential of modulating the ceramide/sphingomyelin pathway. J. Clin. Invest. 110 (2002) 3-8
4. Rosen H., and Goetzl E.J. Sphingosine 1-phosphate and its receptors: an autocrine and paracrine network. Nat. Rev. Immunol. 5 (2005) 560-570
5. Rosen H., et al. Egress: a receptor-regulated step in lymphocyte trafficking. Immunol. Rev. 195 (2003) 160-177
6. Rosen H., and Liao J. Sphingosine 1-phosphate pathway therapeutics: a lipid-receptor paradigm. Curr. Opin. Chem. Biol. 7 (2003) 461-468
7. Murata N., et al. Interaction of sphingosine 1-phosphate with plasma components, including lipoproteins, regulates the lipid receptor-mediated actions. Biochem. J. 352 (2000) 809-815
8. 1 antagonist in vivo. Nat. Chem. Biol. 2 (2006) 434-441
9. 3, respectively, regulate lymphocyte recirculation and heart rate. J. Biol. Chem. 279 (2004) 13839-13848
10. Forrest M., et al. Immune cell regulation and cardiovascular effects of sphingosine 1-phosphate receptor agonists in rodents are mediated via distinct receptor subtypes. J. Pharmacol. Exp. Ther. 309 (2004) 758-768
11. Allende M.L., and Proia R.L. Sphingosine-1-phosphate receptors and the development of the vascular system. Biochim. Biophys. Acta 1582 (2002) 222-227
12. 1 acts within endothelial cells to regulate vascular maturation. Blood 102 (2003) 3665-3667
13. Wei S.H., et al. Sphingosine 1-phosphate type 1 receptor agonism inhibits transendothelial migration of medullary T cells to lymphatic sinuses. Nat. Immunol. 6 (2005) 1228-1235
14. Brinkmann V., and Baumruker T. Pulmonary and vascular pharmacology of sphingosine 1-phosphate. Curr. Opin. Pharmacol. 6 (2006) 244-250
15. McVerry B.J., et al. Sphingosine 1-phosphate reduces vascular leak in murine and canine models of acute lung injury. Am. J. Respir. Crit. Care Med. 170 (2004) 987-993
16. McVerry B.J., and Garcia J. In vitro and in vivo modulation of vascular barrier integrity by sphingosine 1-phosphate: mechanistic insights. Cell. Signal. 17 (2005) 131-139
17. Liu Y., et al. Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation. J. Clin. Invest. 106 (2000) 951-961
18. Singer I.I., et al. Sphingosine-1-phosphate agonists increase macrophage homing, lymphocyte contacts, and endothelial junctional complex formation in murine lymph nodes. J. Immunol. 175 (2005) 7151-7161
19. Sanchez T., et al. Phosphorylation and action of the immunomodulator FTY720 inhibits VEGF-induced vascular permeability. J. Biol. Chem. 278 (2003) 47281-47290
20. Lo C.G., et al. Cyclical modulation of sphingosine-1-phosphate receptor 1 surface expression during lymphocyte recirculation and relationship to lymphoid organ transit. J. Exp. Med. 201 (2005) 291-301
21. Schultz C. Lipid-induced phenotypes. Nat. Chem. Biol. 2 (2006) 396-398
22. Davis M.D., et al. Sphingosine 1-phosphate analogs as receptor antagonists. J. Biol. Chem. 280 (2005) 9833-9841
23. Parrill A.L., et al. Identification of Edg1 receptor residues that recognize sphingosine 1-phosphate. J. Biol. Chem. 275 (2000) 39379-39384
24. Sardar V.M., et al. Molecular basis for the lysophosphatidic acid receptor agonist selectivity. Biochim. Biophys. Acta 1582 (2002) 309-317
25. 1 (EDG1) and LPA1 (EDG2) phospholipid growth factor receptors. J. Biol. Chem. 276 (2001) 49213-49220
26. Brinkmann V., et al. The immune modulator FTY720 targets sphingosine 1-phosphate receptors. J. Biol. Chem. 277 (2002) 21453-21457
27. Brinkmann V., and Lynch K. FTY720: targeting G-protein-coupled receptors for S1P in transplantation and autoimmunity. Curr. Opin. Immunol. 14 (2002) 569-575
28. Pan S., et al. A monoselective sphingosine-1-phosphate receptor-1 agonist prevents allograft rejection in a stringent rat heart transplantation model. Chem. Biol. 13 (2006) 1227-1234
29. Foss F., et al. Synthesis and biological evaluation of γ-aminophosphonates as potent, subtype-selective sphingosine 1-phosphate receptor agonists and antagonists. Bioorg. Med. Chem. 15 (2007) 663-677
30. 1 receptors. Eur. J. Immunol. 36 (2006) 149-159
31. Matloubian M., et al. Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature 427 (2004) 355-360
32. 1-selective in vivo-active agonists from high-throughput screening: off-the-shelf chemical probes of receptor interactions, signaling, and fate. Chem. Biol. 12 (2005) 703-715
33. Owens J. Modulating molecular gateways. Nature Rev. Drug Discov. 5 (2006) 633
34. 1, on T-cells controls thymic emigration. J. Biol. Chem. 279 (2004) 15396-15401
35. Rosen H., et al. Rapid induction of medullary thymocyte phenotypic maturation and egress inhibition by nanomolar sphingosine 1-phosphate receptor agonist. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 10907-10912
36. Yagi H., et al. Immunosuppressant FTY720 inhibits thymocyte emigration. Eur. J. Immunol. 2000 (2000) 1435-1444
37. Feng C., et al. A potential role for CD69 in thymocyte emigration. Int. Immunol. 14 (2002) 535-544
38. Nakayama T., et al. The generation of mature, single-positive thymocytes in vivo is dysregulated by CD69 blockade or overexpression. J. Immunol. 168 (2002) 87-94
39. 1 and lymphocyte egress from lymphoid organs. Nature 440 (2006) 540-544
40. Miller M.J., et al. Two-photon imaging of lymphocyte motility and antigen response in intact lymph node. Science 296 (2002) 1869-1873
41. Wei S.H., et al. A stochastic view of lymphocyte motility and trafficking within the lymph node. Immunol. Rev. 195 (2003) 136-159
42. Tilley D.G., and Rockman H. Role of β-adrenergic receptor signaling and desensitization in heart failure: new concepts and prospects for treatment. Expert Rev. Cardiovasc. Ther. 4 (2006) 417-432
43. Jolly P.S., et al. The roles of sphingosine-1-phosphate in asthma. Mol. Immunol. 38 (2002) 1239-1245
44. Milojevic T., et al. The ubiquitin-specific protease Usp4 regulates the cell surface level of the A2a receptor. Mol. Pharmacol. 69 (2006) 1083-1094
45. 1D-adrenergic receptors form a single functional entity. Mol. Pharmacol. 69 (2006) 45-55
46. Hay D.L., et al. GPCR modulation by RAMPs. Pharmacol. Ther. 109 (2006) 173-197
47. Chun J., and Rosen H. Lysophospholipid receptors as potential drug targets in tissue transplantation and autoimmune diseases. Curr. Pharm. Des. 12 (2006) 161-171
48. 1) with high selectivity against all other known S1P receptor subtypes. Bioorg. Med. Chem. Lett. 16 (2006) 3679-3683
49. Shimizu H., et al. KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts. Circulation 111 (2005) 222-229
50. Osada M., et al. Enhancement of sphingosine 1-phosphate-induced migration of vascular endothelial cells and smooth muscle cells by an EDG-5 antagonist. Biochem. Biophys. Res. Commun. 299 (2002) 483-487
51. B2 sphingosine 1-phosphate receptor in neuronal excitability. Eur. J. Neurosci. 14 (2001) 203-209
52. 2 sphingosine 1-phosphate receptor is essential for auditory and vestibular function. Hear. Res. 220 (2006) 38-48
53. B3/EDG-3. J. Biol. Chem. 277 (2002) 25152-25159
54. Gonzalez-Cabrera, P.J. et al. Mapping pathways downstream of S1P1 by differential chemical perturbation and proteomics. J. Biol. Chem. (in press)